Skip to content
2000
Volume 9, Issue 5
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Helper-dependent adenoviral vectors (HDAd) have several characteristics making them very attractive for human gene therapy. These vectors are completely devoid of viral coding sequences and are able to mediate high efficiency transduction in vivo to direct high level transgene expression with negligible chronic toxicity. Progress towards liver and lung directed gene therapy with HDAd as well as the current obstacles facing human applications and possible strategies to overcome these obstacles are discussed.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/156652309789753310
2009-10-01
2025-10-27
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/156652309789753310
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test